ARBITER-2 : evidence that targeting HDL cholesterol slows atherosclerosis.
D002339:Carotid Arteries / Q000473:pathology; D008076:Cholesterol, HDL / Q000097:blood; D003324:Coronary Artery Disease / Q000473:pathology / Q000517:prevention & control*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D017539:Tunica Intima / Q000473:pathology
D008076:Cholesterol, HDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin